CMXTwenty's Seed Round

CMXTwenty raised a round of funding on March 29, 2018. Investors include BrightStar Wisconsin.

Cmxtwenty is a Milwaukee-based pharmaceutical company focused on development of a non-narcotic treatment for pain using a unique lipid molecule called CMX-020. This molecule is an analog of arachidoni…

Articles about CMXTwenty's Seed Round: